Hyoscine Butyl Bromide
规格
[(1R,2R,4S,5S)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate bromideIUPAC 名称
C21H30BrNO4化学式
440.4 g/mol分子量
N-Butylscopolammonium bromide; RefChem:55683; Buscopan Injectable Solution; scopolamine butylbromide; 149-64-4; Hyoscine butylbromide; Buscopan; Scobutil; Scopolan; Sporamin; Buscolysin; Amisepan; Buscapina; Buscapine; Butylmin; Donopon; Joscine; Monospan; Scobron; Scobutyl; Sparicon; Tirantil; Buscol; Scobro; Buscolamin; BUTYLSCOPOLAMMONIUM BROMIDE; Butylscopolamine bromide; Scopolamine bromobutylate; Hyoscine-N-butyl bromide; Buscolysine; Stilbron; Hyoscine butyl bromide; scopolamine n-butylbromide; Scopolamine butobromide; N-Butylhyoscine bromide; Scoburen; Stibron; Hyoscin-N-butyl bromide; Scopolamine butyl bromide; N-Butylhyoscinium bromide; N-Butylscopolamine bromide; Scopolamine N-butyl bromide; N-Butylscopolaminium bromide; (-)-N-Butylscopolamine bromide; DTXSID1022718; MFCD00078561; (-)-SCOPOLAMINE N-BUTYL BROMIDE; MLS000069755; 0GH9JX37C8; Butylhyoscine; SMR000058795; 9-epi-Hyoscine Butylbromide; DTXCID102718; (-)-Scopolamine-N-butylbromide; (1R,2R,4S,5S,7s,9S)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide; [(1S,2S,4R,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide; 150521-07-6; CAS-149-64-4; Hyoscine butobromide; Hyoscin-N-butylbromid; butylscopolamin; C21H30BrNO4; UNII-0GH9JX37C8; Buskolamin; Antipan; Buscogast; Hyocimax; Scopinal; Spasmin; HybroCare; Butylscopolamine bromide [JAN]; SR-01000759230; Hyoscin-N-butylbromid [German]; butylscopolaminium; Spasler-P; hyoscin butobromide; (1R,2R,4S,5S,7s,9R)-9-Butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide; (1R,2R,4S,5S,7s,9R)-9-Butyl-7-[[(S)-3-hydroxy-2-phenylpropanoyl]oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium Bromide; (1S,2R,4S,5S)-9-butyl-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide; EINECS 205-744-1; Hyoscine Butylbromide EP Impurity F; Hyoscine N-Butylbromide; Opera_ID_556; Scopolamine impurity 24; Hyoscine N-butyl bromide; scopolamine-n-butylbromide; Hyoscine butylbromide CRS; NCGC00163224-01; Scopolamine N-n-butylbromide; SCHEMBL25291; (-)-Scopolamine Butylbromide; MLS002153372; MLS006013629; orb104751; orb3027364; CHEMBL1256901; SCHEMBL29373202; CHEBI:32123; HOZOZZFCZRXYEK-GSWUYBTGSA-M; HOZOZZFCZRXYEK-HNHWXVNLSA-M; Hyoscine butylbromide; (-)-Scopolamine butylbromide; Butylscopolamine bromide; HMS2235K20; HMS3714I19; HMS3884J15; Butylscopolamine bromide [WHO-DD]; HY-N0340; MSK11325; Tox21_112031; EBC-27103; HYOSCINE BUTYLBROMIDE [MART.]; SCOPOLAMINE BUTYLBROMIDE [JAN]; AKOS016009548; AKOS037515799; Tox21_112031_1; CCG-208412; CS-3142; FS10191; NCGC00186628-02; AC-34139; AS-78017; N-BUTYLSCOPOLAMMONIUM BROMIDE [MI]; PD087140; SMR004705104; SY108844; HYOSCINE BUTYLBROMIDE [EP MONOGRAPH]; BUTYLSCOPOLAMINE BROMIDE [GREEN BOOK]; NS00079272; F17660; EN300-7394481; SR-01000759230-3; (-)-Scopolamine N-butyl bromide, >=98% (TLC), powder; Hyoscine butylbromide, British Pharmacopoeia (BP) Reference Standard; Hyoscine butylbromide, European Pharmacopoeia (EP) Reference Standard; (1R,2R,4S,5S,7R)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,2,4]nonan-9-ium bromide; (1R,2R,4S,5S,7s)-9-Butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-9-ium bromide; (1R,2R,4S,5S,7S)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide; (2R,4S,5S,7s)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane bromide; [(1S,2S,4R,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenyl-propanoate;bromide; 1-alpha-H,5-alpha-H-Tropanium, 8-butyl-6-beta,7-beta-epoxy-3-alpha-hydroxy-, bromide, (-)-tropate; 3-OXA-9-AZONIATRICYCLO(3.3.1.0 SUP(2,4))NONANE, 9-BUTYL-7-((2S)-3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9-METHYL-, BROMIDE (1:1),(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-; 3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-; 9-epi-Hyoscine Butylbromide; 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, stereoisomer (9CI); 3-Oxa-9-azatricyclo[3.3.1.02,4]nonane, 3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane deriv.; (1R,2R,4S,5S,7s,9s)-9-butyl-7-[[(2S)-3-hy同义词
